{"id":330,"date":"2021-01-21T07:40:35","date_gmt":"2021-01-21T07:40:35","guid":{"rendered":"https:\/\/mph.nycu.edu.tw\/?page_id=330"},"modified":"2022-05-11T13:40:00","modified_gmt":"2022-05-11T05:40:00","slug":"%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88","status":"publish","type":"page","link":"https:\/\/mph.nycu.edu.tw\/en\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/","title":{"rendered":"Professor Yu-Li Lo"},"content":{"rendered":"
\"\"
Professor Yu-Li Lo<\/figcaption><\/figure><\/div>\n\n\n\n

\u25cf Office:<\/strong>\u5b88\u4ec1\u6a135\u6a13516\u5ba4<\/p>\n\n\n\n

\u25cf Contact number:<\/strong>(02) 2826-7000 #66451<\/p>\n\n\n\n

\u25cf E-mail\uff1a<\/strong><\/p>\n\n\n\n

yulilo@nycu.edu.tw<\/p>\n\n\n\n

<\/p>\n\n\n\n

\u25cf Education<\/strong><\/p>\n\n\n\n

\u7f8e\u570b\u660e\u5c3c\u8607\u9054\u5927\u5b78 \u85e5\u5291\u5b78\u7814\u7a76\u6240\u535a\u58eb<\/p>\n\n\n\n

\u570b\u7acb\u81fa\u7063\u5927\u5b78 \u85e5\u5b78\u7cfb\u5b78\u58eb<\/p>\n\n\n\n

\u25cf Experience<\/strong><\/p>\n\n\n\n

\u25cb \u570b\u7acb\u81fa\u5357\u5927\u5b78 \u751f\u7269\u79d1\u6280\u5b78\u7cfb\u6559\u6388<\/p>\n\n\n\n

\u25cb \u570b\u7acb\u81fa\u5357\u5927\u5b78 \u751f\u7269\u79d1\u6280\u5b78\u7cfb\u4e3b\u4efb<\/p>\n\n\n\n

\u25cb \u570b\u7acb\u81fa\u5357\u5927\u5b78 \u751f\u7269\u79d1\u6280\u5b78\u7cfb\u78a9\u58eb\u73ed\u6240\u9577<\/p>\n\n\n\n

\u25cb \u570b\u7acb\u81fa\u5357\u5927\u5b78 \u751f\u7269\u8cc7\u6e90\u8207\u79d1\u6280\u7814\u7a76\u6240\u6240\u9577<\/p>\n\n\n\n

\u25cb \u570b\u7acb\u6210\u529f\u5927\u5b78\u91ab\u5b78\u9662 \u81e8\u5e8a\u85e5\u5b78\u8207\u85e5\u7269\u79d1\u6280\u7814\u7a76\u6240\u517c\u4efb<\/p>\n\n\n\n

\u25cb \u660e\u5c3c\u8607\u9054\u5927\u5b78 \u85e5\u5291\u7814\u7a76\u6240\u7814\u7a76\u52a9\u7406<\/p>\n\n\n\n

\u25cb \u660e\u5c3c\u8607\u9054\u5927\u5b78 \u85e5\u5291\u7cfb\u52a9\u6559<\/p>\n\n\n\n

\u25cb \u570b\u7acb\u81fa\u7063\u5927\u5b78 \u85e5\u5b78\u7cfb\u52a9\u6559<\/p>\n\n\n\n

\u25cf \u7814\u7a76\u4e3b\u984c\uff1a<\/strong>\u5948\u7c73\u6a19\u9776\u8f09\u9ad4\u61c9\u7528\u65bc\u7cbe\u6e96\u5316\u764c\u75c7\u6cbb\u7642\u8207\u8ffd\u8e64<\/p>\n\n\n\n

\u25cf Professional Specialty<\/strong><\/p>\n\n\n\n

1. \u958b\u767c\u6297\u83cc\u80dc\u80bd\u4f5c\u70ba\u6297\u764c\u85e5\u7269\u4e4b\u65b0\u4f50\u5291<\/p>\n\n\n\n

2. \u751f\u6280\u91ab\u85e5\u5291\u578b\u8a2d\u8a08<\/p>\n\n\n\n

3. \u751f\u91ab\u5948\u7c73\u88fd\u5291\u7814\u767c<\/p>\n\n\n\n

4. \u8abf\u63a7\u764c\u75c7\u6cbb\u7642\u4e4b\u591a\u91cd\u6297\u85e5\u6027<\/p>\n\n\n\n

5. \u53cd\u7fa9\u5be1\u6838\u9178\u5291\u578b\u7814\u767c<\/p>\n\n\n\n

6. \u5e72\u64fe\u6027\u6838\u91a3\u6838\u9178\u4e4b\u6297\u764c\u88fd\u5291<\/p>\n\n\n\n

7. \u7570\u9ec3\u916e\u884d\u751f\u7269\u6297\u764c\u6d3b\u6027\u7be9\u9078<\/p>\n\n\n\n

8. \u751f\u91ab\u9ad8\u5206\u5b50\u53ca\u539f\u4f4d\u6210\u81a0<\/p>\n\n\n\n

9. \u5948\u7c73\u5fae\u8102\u7c92\u4e4b\u51b7\u51cd\u4e7e\u71e5\u53ca\u5674\u9727\u4e7e\u71e5\u5291\u578b<\/p>\n\n\n\n

\u25cf Research interest<\/strong><\/p>\n\n\n\n

\u00d8  \u8a2d\u8a08\u6eab\u5ea6\u6216\u74b0\u5883\u654f\u611f\u53ca\u80dc\u80bd\u4fee\u98fe\u7684\u5948\u7c73\u7c92\u4f5c\u70ba\u591a\u529f\u80fd\u6a19\u7684\u6cbb\u7642\u4e4b\u8f38\u9001\u8f09\u9ad4<\/p>\n\n\n\n

\u00d8  \u53ef\u89e3\u96e2\u7684\u816b\u7624\u6a19\u9776\u5948\u7c73\u7c92\u4f5c\u70ba\u764c\u75c7\u85e5\u7269\u53ca\u57fa\u56e0\u7d44\u5408\u7642\u6cd5\u4e4b\u8f09\u9ad4<\/p>\n\n\n\n

\u00d8  \u767c\u5c55CRISPR\/Cas\u3001\u5fae\u5c0f\u6838\u91a3\u6838\u9178\u3001\u53cd\u7fa9\u5be1\u6838\u82f7\u9178<\/p>\n\n\n\n

\u6216\u5e72\u64fe\u6838\u91a3\u6838\u9178\u53ca\u6297\u764c\u85e5\u7269\u4e4b\u5948\u7c73\u7c92\u4f5c\u70ba\u6297\u764c\u65b0\u88fd\u5291<\/p>\n\n\n\n

\u00d8  \u7814\u767c\u6eab\u5ea6\u53ca\u9178\u9e7c\u96d9\u61c9\u7b54\u578b\u5171\u805a\u9ad8\u5206\u5b50\u6c34\u81a0\u4f5c\u70ba\u6297\u764c\u85e5\u6216\u773c\u85e5\u65b0\u5291\u578b<\/p>\n\n\n\n

\u00d8  \u958b\u767c\u6297\u83cc\u80dc\u80bd\u53ca\u5929\u7136\u7269\u4f5c\u70ba\u6297\u764c\u85e5\u7269\u65b0\u4f50\u5291<\/p>\n\n\n\n

\u00d8  \u958b\u767c\u5674\u9727\u4e7e\u71e5\u86cb\u767d\u8cea\u5fae\u8102\u7c92\u4e4b\u5438\u5165\u7d66\u85e5\u6a21\u5f0f<\/p>\n\n\n\n

\u00d8  \u8a2d\u8a08\u8907\u5408\u5948\u7c73\u914d\u65b9\u4ee5\u8abf\u63a7\u8840\u7cd6\u548c\u8840\u8102<\/p>\n\n\n\n

\u00d8  \u5177\u6f5b\u529b\u6297\u6c27\u5316\u53ca\u6297\u8001\u5316\u6210\u5206\u4e4b\u65b0\u5291\u578b\u7814\u767c<\/p>\n\n\n\n

\n

\u25cf Books (or research publications)<\/strong> <\/p>\n\n\n\n

\u25cb \u671f\u520a\u8ad6\u6587<\/strong><\/p>\n\n\n\n

1. Juang, V., Chang, C.H., Wang, C.S., Chen, Y.C., Wang, H.E., Lo, Y.L.<\/u><\/strong>*<\/em> pH-responsive PEG-shedding and targeting peptide-modified nanoparticles for dual-delivery of irinotecan and microRNA to enhance tumor-specific therapy. Small<\/strong>: in press (SCI; IF = 10.856; Rank = 6.8% in Materials Science, Multidisciplinary).<\/p>\n\n\n\n

2. Hong, S.T., Lin, Huaching, Wang, C.S., Chang, C.H., Lin, A.M.Y., Yang, C.H.J., Lo, Y.L.<\/u><\/strong>*<\/em>(2019) Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides. Journal of Nanobiotechnology<\/strong>Aug 19;17(1):89 (SCI; IF = 5.345; Rank = 11% in Biotechnology & Applied Microbiology).<\/p>\n\n\n\n

3. Chen, Y.J., Hsu, C.C., Shiao, Y.J., Wang, H.T.,Lo, Y.<\/u><\/strong>L.<\/u><\/strong>*<\/strong>, Lin, A.M.Y.*(2019) Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation. Scientific Reports<\/strong>9(1):2516 (SCI; IF = 4.011; Rank = 21.74% in Multidisciplinary Sciences).<\/p>\n\n\n\n

4. Yang, C.P., Shiau,M.Y.,Lai, Y.R., Ho, K.T.,Hsiao, C.W., Chen, C.J., Lo, Y.L.<\/u><\/strong>, Chang, Y.H.* (2018) Interleukin-4 boosts insulin-induced energy deposits by enhancing glucose uptake and lipogenesis in hepatocytes. Oxid Med Cell Longev.<\/strong> (Oxidative Medicine and Cellular Longevity)6923187 (SCI; IF = 4.868; Rank = 29.02% in Cell Biology).<\/p>\n\n\n\n

5. Zhao, W.Z., Wang, H.T., Huang, H.J., Lo, Y.<\/u><\/strong>L.<\/u><\/strong>*<\/strong>, Lin, A.M.Y.* (2018) Neuroprotective effects of baicalein on acrolein-induced neurotoxicity in the nigrostriatal dopaminergic system of rat brain. Molecular Neurobiology<\/strong> 55(1): 130 (SCI; IF = 4.586; Rank = 21.35% in Neurosciences).<\/p>\n\n\n\n

6. Lin, G.L., Ting, H.J., Tseng, T.C.,Juang, V.,Lo, Y.L.<\/u><\/strong>*<\/strong>(2017) Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells PLoS One<\/strong> 12(10): e0185625 (SCI; IF = 2.78; Rank = 34.78% in Multidisciplinary Sciences; MOST 104-2320-B-010-004-MY2; MOST 106-2320-B-010-005).<\/p>\n\n\n\n

7. Wang, H.T.*, Lin, J.H., Yang, C.H, Haung, C.H., Weng, C.W., Lin, A.M.Y., Lo, Y.L.<\/u><\/strong>, Chen, W.S., Tang, M.S.(2017)Acrolein induces mtDNA damages, mitochondrial fission and mitophagy in human lung cells.Oncotarget<\/strong>8:70406 (SCI; IF = 5.168; Rank = 20.28% in Oncology).<\/p>\n\n\n\n

8. Wang, Y.T., Lin, H.C., Zhao, W.Z., Huang, H.J.,Lo, Y.L.<\/u><\/strong>, Wang, H.T.*, Lin, A.M.Y.* (2017) Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat:involvement of \u03b1-synuclein aggregation and programmed cell death. Scientific Reports<\/strong>7:45741-45749 (SCI; IF = 4.011; Rank = 21.74% in Multidisciplinary Sciences; MOST 104-2320-B-010-016).<\/p>\n\n\n\n

9. Lin, K.H., Hong, S.T., Wang, H.T., Lo, Y.L.<\/u><\/strong>*<\/strong>, Lin, A.M.Y.*, Yang, C.H.J. (2016) Enhancing anticancer effect of gefitinib across the blood-brain barrier model using liposomes modified with one alpha-helical cell-penetrating peptide or glutathione and Tween 80.Int. J. Mol. Sci.<\/strong>17 (12):1998-2014(SCI; IF = 4.183; Rank = 26.74% in Biochemistry & Molecular Biology; MOST 104-2320-B-010-004-MY2; VGHUST105-G7-8-3;<\/a> V105C-031).<\/p>\n\n\n\n

10. Juang, V.,Lee, H.P., Lin, A.M.Y.<\/a>,Lo, Y.L.*<\/u><\/strong>(2016) Cationic PEGylated liposomes incorporating an antimicrobial peptide hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells. Int. J. Nanomedicine <\/strong>11:6047\u20136064(SCI; IF = 4.47; Rank = 12.73% in Pharmacology & Pharmacy; MOST 104-2320-B-010-004-MY2; VGHUST105-G7-8-3).<\/p>\n\n\n\n

11. Lo, Y.L.<\/u><\/strong>*<\/strong>,Lee, H.P., Tu, W.C.(2015) The use of a liposomal formulation incorporating an antimicrobial peptide from tilapia as a new adjuvant to epirubicin in human squamous cell carcinoma and pluripotent testicular embryonic carcinoma cells. Int. J. Mol. Sci.<\/strong>16 (9):22711-22734(SCI; IF = 4.183; Rank = 26.74% in Biochemistry & Molecular Biology).<\/p>\n\n\n\n

12. Lo, Y.L.<\/u><\/strong>*<\/strong>, Tu, W.C. (2015) Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells. Chemico-Biological Interactions<\/strong>242:13-23(SCI; IF = 3.41; Rank = 29% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

13. Lo, Y.L.<\/u><\/strong>*<\/strong>, Liu, Y. (2014) Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2\/BCL-xL using liposomal antisense oligonucleotides.PLoS One<\/strong>9(3): e90180 (SCI; IF = 2.78; Rank = 34.78% in Multidisciplinary Sciences).<\/p>\n\n\n\n

14. Lo, Y.L.<\/u><\/strong>*<\/strong>,Lin, Y, Lin, H.R. (2014) Evaluation of epirubicin in thermogelling and bioadhesive liquid and solid suppository formulations for rectal administration. Int. J. Mol. Sci.<\/strong> 15 (1):342-360(SCI; IF = 4.183; Rank = 26.74% in Biochemistry & Molecular Biology).<\/p>\n\n\n\n

15. Lee, Y.K., Lin, T.H. Chang, C.F.*<\/sup>, Lo, Y.L.<\/u><\/strong>*<\/strong>(2013) Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosispathway via \u03b2-catenin\/GSK-3\u03b2 modulation in colorectal carcinoma.PLoS One<\/strong><\/a>8 (11): e82478 (SCI; IF = 2.78; Rank = 34.78% in Multidisciplinary Sciences).<\/p>\n\n\n\n

16. Lo, Y.L.<\/u><\/strong>*<\/strong>, Wang, W.J. (2013) Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chemico-Biological Interactions<\/strong>205 (3):188-197(SCI; IF =3.41; Rank = 29% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

17. Lin, HR., Hsu, C.Y., Lo, Y.L.<\/u><\/strong>*<\/strong>(2013) Preparation and characterization of dual phase transition oral hydrogel for sustained release of epirubicin.International Journal of Polymeric Materials<\/strong><\/a> and Polymeric Biomaterials<\/strong>62(14):763-769(SCI; IF = 2.127; 35.06% in Polymer Science).<\/p>\n\n\n\n

18. Lo, Y.L.<\/u><\/strong>*<\/strong>, Liu, Y., Tsai, J. C. (2013)Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo. Biomed. Pharmacother.<\/strong> 67 (4):261-267(SCI; IF = 3.457; 26% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

19. Lo, Y.L.<\/u><\/strong>* <\/strong>(2013) A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells. Int. J. Mol. Sci.<\/strong> 14 (1):158-176 (SCI; IF = 4.183; Rank = 26.74% in Biochemistry & Molecular Biology).<\/p>\n\n\n\n

20. Lo, Y.L.<\/u><\/strong>*<\/strong>, Hsu, C.Y., Lin, H.R.*<\/strong>(2013) pH- and thermo-sensitive pluronic\/poly(acrylic acid) in situ<\/em> hydrogels for sustained release of an anticancer drug. J. Drug Target.<\/strong> 21 (1):54-66 (SCI; IF = 3.408; 27% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

21. Lo, Y.L.<\/u><\/strong>*<\/strong>, Wang, W.J., Ho, C.T. (2012) 7,3′,4′-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species. Toxicology<\/strong> 302 (2-3):221-232 (SCI; IF = 3.265; 27% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

22. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ho, C.T., Tsai, F.L. (2008) Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.Eur. J. Pharm. Sci.<\/strong> 35(1-2): 52-67 (SCI; IF = 3.5; 26% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

23. Lin, H. R.*, Yu, S. P., Kuo, C.J., Kao, H.J., Lo, Y. L.<\/u><\/strong>, Lin, Y.J. (2007) Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery. J. Biomaterials Science-Polymer Edition<\/strong> 18(2):205-221 (SCI; IF = 1.911;Rank: 41.95% in Polymer Science).<\/p>\n\n\n\n

24. Kao, H.J., Lo, Y. L.<\/u><\/strong>, Vong, W. J., and Lin, H. R.* (2006) Treating allergic conjunctivitis using in situ polyelectrolyte gelling systems.J. Biomaterials Science-Polymer Edition <\/strong>17(10):1191-1205 (SCI; IF = 1.911;Rank: 41.95% in Polymer Science).<\/p>\n\n\n\n

25. Kao, H.J., Lin, H. R., Lo, Y. L.*<\/u><\/strong>, and Yu, S. P. (2006) Characterization of pilocarpine-loaded chitosan\/carbopol nanoparticles.J. Pharm. Pharmacol. <\/strong>58(2): 179-186 (SCI; IF = 2.309;Rank: 55.75% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

26. Lo, Y. L.*<\/u><\/strong>, <\/strong>Tsai, J. C., Kuo, J. H. (2004)L<\/a>iposomes and disaccharides as carriersin spray-dried powder formulations of superoxide dismutase.J. Control. Release<\/strong>94 (2-3): 259-272<\/a> (SCI; IF = 7.901; Rank = 3.3%in Pharmacology & Pharmacy).<\/p>\n\n\n\n

27. Tsai, J.C.*<\/strong>, Lo, Y. L<\/u><\/strong>., Lin, C.Y., Sheu, H.M., and Lin, J.C. (2004)Feasibility of rapidquantitation of stratum corneum lipid content by Fourier transform infrared spectrometry. Spectroscopy <\/strong>18: 423-431 (SCI; IF = 0.86;Rank: 77.91% in Spectroscopy).<\/p>\n\n\n\n

28. Lo, Y. L.<\/u><\/strong>* (2003) Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines.J. Control. Release<\/strong> 90 (1): 37-48(SCI; IF = 7.901; Rank = 3.3% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

29. Tsai, J. C.*<\/strong>, Lin, C. Y., Sheu, H. M., and Lo, Y. L<\/u><\/strong>. (2003) Noninvasive characterization of regional variation in drug transport across human stratum corneum in vivo<\/em>.Pharm. Res.<\/strong> 20(4): 632-638(SCI; IF = 3.335;Rank: 28.16% inPharmacology & Pharmacy). <\/p>\n\n\n\n

30. Kuo, J. H., Lo, Y. L.<\/u><\/strong>, Shau, M. D., Cherng, J. Y.*<\/strong> (2002) A thermodynamic study of cationic polymer-plasmid DNA complexes by high-sensitive differential scanning calorimetry. J. Control. Release<\/strong> 81(3): 321-325 (SCI; IF = 7.901; Rank = 3.3% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

31. Tsai, J. C.*<\/strong>, Chen, I. H., Wong, T. K., and Lo, Y. L<\/u><\/strong>. (2002)In vitro\/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.Br. J. Dermatology <\/strong>146: 853-862 (SCI; IF = 6.129;Rank: 5.47% in Dermatology).<\/p>\n\n\n\n

32. Lo, Y. L.<\/u><\/strong>,Liu, F. I., and Cherng, J. Y.*<\/strong>(2001) Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines. J. Control. Release<\/strong>76: 1-10(SCI; IF = 7.901; Rank = 3. 3% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

33. Lo, Y. L.<\/u><\/strong>*<\/strong> (2000) Phospholipids as multidrug resistance modulators on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol.<\/strong> 60: 1381-1390 (SCI; IF = 4.235;Rank: 13.60% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

34. Lo, Y. L.<\/u><\/strong>*<\/strong>,Liu, F. I., Yang, J. M., and Cherng, J. Y. (2001) Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid. Anticancer Res.<\/strong>21(1A): 445-450 (SCI; IF = 1.9;Rank: 82% in Oncology).<\/p>\n\n\n\n

35. Lo, Y. L.<\/u><\/strong>*<\/strong> and Huang, J. D. (2000) Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol.<\/strong> 59: 665-672 (SCI; IF = 4.235;Rank: 13.60% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

36. Lo, Y. L.<\/u><\/strong>*<\/strong> and Huang, J. D. (1999) Comparison of effects of natural or artificial rodent diet on etoposide absorption in rats. In Vivo<\/strong> 13: 51-56 (SCI; IF = 1.116;Rank: 85% in Medicine, Research & Experimental).<\/p>\n\n\n\n

37. Lo, Y. L.<\/u><\/strong>*<\/strong>(1999)Use of phospholipids to enhance the intestinal absorption of epirubicin. Chia-Nan Annu. Bull.<\/strong>25: 139-146(NSC 88-2314-B-041-009).<\/p>\n\n\n\n

38. Lo, Y. L.<\/u><\/strong>*<\/strong>, Hsu, C. Y. and Huang, J. D. (1998) Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line. Anticancer Res.<\/strong> 18: 3005-3009 (SCI; IF = 1.9;Rank: 82% in Oncology).<\/p>\n\n\n\n

39. Lo, Y. L.<\/u><\/strong>*, <\/strong>Hsu, L. R., Song, C. L., Tsaz, Y. F., Chen, C. M., and Wu, D. H. (1998) Use of Cremophor EL as a MDR reversing agent to enhance intestinal absorption of epirubicin in everted gut sacs of rats and human intestinal epithelial Caco-2 cell layers. Chia-Nan Annu. Bull.<\/strong> 24: 142-149 (NSC 87-2314-B-041-008).<\/p>\n\n\n\n

40. Lo, Y. L.<\/u><\/strong>* and Rahman, Y. E. (1998) Effect of lipids on the thermal stability and conformational changes of proteins: Ribonuclease A and cytochrome c. Int. J. Pharm.<\/strong> 161(2): 137-148 (SCI; IF = 3.9;Rank: 17%inPharmacology & Pharmacy).<\/p>\n\n\n\n

41. Lo, Y. L.<\/u><\/strong>*, Hsu, C. Y. and Huang, J. D. (1997) Use of pharmaceutical excipient Cremophor EL for enhancing intracellular accumulation of epirubicin in Caco-2 cell line.Chia-Nan Annu. Bull.<\/strong> 23: 18-24.<\/p>\n\n\n\n

42. Lo, Y. L.<\/u><\/strong> and Rahman, Y. E.*<\/strong> (1996) Interaction between superoxide dismutase and dipalmitoylphosphotidylglycerol bilayers: a fourier transform infrared (FT-IR) spectroscopic study. Pharm. Res.<\/strong> 13(2): 265-271 (SCI; IF = 3.3;Rank: 28% inPharmacology & Pharmacy).<\/p>\n\n\n\n

43. Lo, Y. L.<\/u><\/strong>*<\/strong> and Rahman, Y. E. (1995) Protein location in liposomes, a drug carrier: a prediction by differential scanning calorimetry. J. Pharm. Sci.<\/strong> 84(7): 805-814 (SCI; IF = 3.1; Rank: 34.7% in Pharmacology & Pharmacy).<\/p>\n\n\n\n

\u25cb \u7814\u8a0e\u6703\u8ad6\u6587<\/strong>\uff08\u5171\u8a08\u767c\u8868\u56db\u5341\u516b\u7bc7\u8ad6\u6587\u65bc\u570b\u969b\u7814\u8a0e\u6703\u53ca\u4e94\u5341\u56db\u7bc7\u8ad6\u6587\u65bc\u570b\u5167\u7814\u8a0e\u6703<\/u><\/strong>\uff09<\/p>\n\n\n\n

1. Lo, Y.L.<\/u><\/strong>*<\/em><\/strong>, Chen, Y.C., Chang, C.H., Tseng, W.H., Wang, C.S.(2019) Tumor-targeted and pH-shiftable nanoparticles to encapsulate oxaliplatin and microRNA for colorectal cancer therapy. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, MA, USA.<\/p>\n\n\n\n

2. Juang, V., Chen, Y.C.,Lo, Y.L.<\/u><\/strong>*<\/em>(2019) The use of EGFR-TKI-loaded lipid polymeric nanoparticles for suppression of colorectal cancer. 2019 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, San Antonio, Texas, USA.<\/p>\n\n\n\n

3. Chang, C.H., Wang, C.S.,Lo, Y.L.<\/u>*<\/em><\/strong>(2019) The use of microRNA- and irinotecan-loaded targeting nanoparticles to improve cancer-specific therapy.2019 Annual Meeting of the Controlled Release Society, Valencia, Spain.<\/p>\n\n\n\n

4. Chang, C.H., Wang, C.S.,Lo, Y.L.<\/u>*<\/em><\/strong> (2019)pH-responsive and targeting peptide-modified nanoparticles for dual-delivery of irinotecan and microRNA to inhibit cancer. 2019 International Advanced Drug Delivery Symposium & Annual Meeting of Biomaterials and Controlled Releases Society in Taiwan, Hsinchu, Taiwan.<\/p>\n\n\n\n

5. Chang, C.H., Wang, C.S.,Lo, Y.L.<\/u>*<\/em><\/strong>(2019) Multifunctional nanoparticles encapsulating chemotherapy and microRNA for tumor suppression. The 34 Joint Annual Conference of Biomedical Science (\u7b2c34\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

6. Lo, Y.L.<\/u><\/strong>*, Juang, V., Lee, H.P., Lin, A.M.Y. (2018) PEGylated liposomes for delivering anticancer drugs and antimicrobial peptides: new approaches for cancer nanomedicines. Taiwan-Japan Joint Symposium, Sapporo, Japan.<\/p>\n\n\n\n

7. Lin, L.Y., Chen, Y.C., Wang, C.S., Lo, Y.L.<\/u>* <\/strong>(2018) The effect of microRNA and natural compound E encapsulated in nanoparticles for inhibition of oral cancer cells. Asia Pacific Pharmaceutical Symposium at Fujiyoshida-shi, Yamanashi-ken, Japan.<\/p>\n\n\n\n

8. Lo, Y.L.<\/u><\/strong>*, <\/strong>Juang, V., Wang, C.S., Lin, G.L., Ting, H.J. (2018) Silencing of human antigen R protein increases the sensitivity of cancer cells to combination therapy.Immuno\u2010Oncology 2018 World Congress (Immuno\u2010Oncology 2018),Vienna, Austria.<\/p>\n\n\n\n

9. Juang, V., Chen, Y.C.,Lo, Y.L.<\/u><\/strong>*<\/em> (2018) Environment-responsive multifunctional nanoparticles encapsulating chemotherapy and microRNA to suppress cancer cells. 2018 Annual Meeting of the Controlled Release Society, New York City, New York, USA.<\/p>\n\n\n\n

10. Chen, Y.C., Juang, V.,Lo, Y.L.<\/u>*<\/em><\/strong>(2018) pH-responsive nanoparticles encapsulating oxaliplatin and microRNA for inhibition of colorectal cancer cells. The 33 Joint Annual Conference of Biomedical Science (\u7b2c33\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

11. Wang, C.S., Lo, Y.L.<\/u>*, <\/strong>Juang, V., Lin, G.L., Ting, H.J. (2018) HuR siRNA reduced resistance to chemotherapy in cancer cells. The 33 Joint Annual Conference of Biomedical Science, Taipei, Taiwan.<\/p>\n\n\n\n

12. Lo, Y.L.<\/u><\/strong>*, <\/strong>Juang, V., Wang, C.S., Lin, G.L., Ting, H.J. (2018) Apoptosis-mediated cell death via human antigen R silencing in colon cancer cells. A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments, Amsterdam, Netherlands.<\/p>\n\n\n\n

13. Chen, Y.C., Juang, V.,Lo, Y.L.<\/u><\/strong>*<\/em>(2018) Environment-responsive nanoparticles carrying chemotherapy and microRNA for suppressing cancer. 2018 Conference of the Pharmaceutical Society of Taiwan, Tainan, Taiwan (2018\u5e74\u53f0\u7063\u85e5\u5b78\u5e74\u6703\u85e5\u5291\u7d44\u53e3\u982d\u8ad6\u6587\u5831\u544a\u512a\u7b49).<\/p>\n\n\n\n

14. Chen, Y.C., Chang, M.H., Li, F.Y., Chu, C.Y., Yang, C.P., Chang, Y.H., Chen, C.J., Lo, Y.L.<\/u>* <\/strong>(2018) Hypoglycemic and hypolipidemic effects of multi-component nanoparticles on adipocytes and obese mice. 2018 Conference of the Pharmaceutical Society of Taiwan, Tainan, Taiwan.<\/p>\n\n\n\n

15. Wang, C.S., Lin, G.L., Ting, H.J.,Lo, Y.L.<\/u>*<\/strong> (2018) siRNA targeting human antigen R protein reduced chemotherapy resistance in cancer cells. 2018 Conference of the Pharmaceutical Society of Taiwan, Tainan, Taiwan.<\/p>\n\n\n\n

16. Juang, V., Chen, Y.C.,Lo, Y.L.<\/u><\/strong>*<\/em>(2017) Characterization and cytotoxicity of microRNA- and irinotecan-loaded multifunctional nanoparticle complex for inhibiting colorectal cancer cells. 2017 AAPS Annual Meeting, San Diego, CA, USA. Pharm. Res.<\/strong> 00(00): S-000 (SCI).<\/p>\n\n\n\n

17. Lo, Y.L.<\/u><\/strong>*<\/em>(2017) Antimicrobial peptides as adjuvants in cationic PEGylated liposomes for delivering antineoplastic agents: a new approach for cancer nanomedicine. 2nd Joint UTAR-UST Symposium on Cancer and Stem Cell Research, Taipei, Taiwan (\u7372\u9080\u6f14\u8b1b).<\/p>\n\n\n\n

18. Juang, V., Chen, Y.C.,Lo, Y.L.<\/u><\/strong>*<\/em>(2017) Peptide-modified liposomes encapsulating irinotecan for inhibition of colorectal cancer. The 32nd Joint Annual Conference of Biomedical Science (\u7b2c32\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

19. Hong, S.T., Lo, Y.L.<\/u><\/strong>*<\/em>, Lin, M.Y. (2017) Afatinib encapsulated in peptides-coated nanoparticles for brain delivery. The 32nd Joint Annual Conference of Biomedical Science (\u7b2c32\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

20. Zhao, W.Z., Wang, H.T., Huang, H.J., Lo, Y.L.<\/u>*<\/strong>, Lin, A.M.Y.* (2017) Neuroprotective effects of baicalein on acrolein-induced neurotoxicity in the nigrostriatal dopaminergic system of rat brain. The 32nd Joint Annual Conference of Biomedical Science (\u7b2c32\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

21. Cheng, Y.N., Yang, C.P., Lo, Y.L.<\/u><\/strong>, Chang, Y.H., Chen, C.J.* (2017) \u5229\u7528 leptin 145E\/145E \u5c0f\u9f20\u52d5\u7269\u6a21\u5f0f\u63a2\u8a0e\u7b2c\u56db\u578b\u4ecb\u767d\u7d20\u8207\u5fae\u5c0fRNA \u5c0d\u8102\u80aa\u5206\u5316\u53ca\u8102\u8cea\u4ee3\u8b1d\u5e73\u8861\u7684\u5f71\u97ff. 2016\u69ae\u53f0\u806f\u5927\u6210\u679c\u767c\u8868\u6703, Taipei, Taiwan.<\/p>\n\n\n\n

22. Yang, C.P., Chen, C.J., Lo, Y.L.<\/u><\/strong>, Chang, Y.H.* (2017) \u5229\u7528 leptin 145E\/145E \u5c0f\u9f20\u52d5\u7269\u6a21\u5f0f\u63a2\u8a0e\u7b2c\u56db\u578b\u4ecb\u767d\u7d20\u8207\u5fae\u5c0fRNA \u5c0d\u8102\u80aa\u5206\u5316\u53ca\u8102\u8cea\u4ee3\u8b1d\u5e73\u8861\u7684\u5f71\u97ff. 2016\u69ae\u53f0\u806f\u5927\u6210\u679c\u767c\u8868\u6703, Taipei, Taiwan.<\/p>\n\n\n\n

23. Li, F.Y., Chu, C.Y., Chen, Y.C., Yang, C.P., Chang, Y.H., Chen, C.J., Lo, Y.L.<\/u>*<\/strong>(2017) \u85e5\u7269\u53ca\u5929\u7136\u7269\u5948\u7c73\u7c92\u5c0dleptin 145E\/145E \u5c0f\u9f20\u52d5\u7269\u6a21\u5f0f\u7684\u6548\u61c9\u63a2\u8a0e. 2016\u69ae\u53f0\u806f\u5927\u6210\u679c\u767c\u8868\u6703, Taipei, Taiwan.<\/p>\n\n\n\n

24. Juang, V.,Lee, H.P., Lin, A.M.Y.,Lo, Y.L.<\/u><\/strong>*<\/em>(2016) Antimicrobial peptide-modified cationic PEGylated liposomes for delivering anticancer drugs to overcome multidrug resistance. 2016 Conference of the Pharmaceutical Society of Taiwan, Taipei, Taiwan (\u7372\u9078\u70ba2016\u5e74\u53f0\u7063\u85e5\u5b78\u5e74\u6703\u85e5\u5291\u7d44\u53e3\u982d\u8ad6\u6587\u5831\u544a).<\/p>\n\n\n\n

25. Lin, K.H., Hong, S.T., Lo, Y.L.<\/u><\/strong>*<\/em>, Lin, M.Y.,Yang, J.C.H. (2016) Enhancing gefitinib delivery across the blood-brain barrier using liposomes modified with peptides. 2016 Conference of the Pharmaceutical Society of Taiwan, Taipei, Taiwan (\u69ae\u73722016\u5e74\u53f0\u7063\u85e5\u5b78\u5e74\u6703\u66a8\u5b78\u8853\u7814\u8a0e\u6703\u58c1\u5831\u6bd4\u8cfd\u85e5\u5291\u7d44\u7b2c\u4e00\u540d).<\/p>\n\n\n\n

26. Li, F.Y., Chu, C.Y., Chen, Y.C., Yang, C.P., Chang, Y.H.,Lo, Y.L.*<\/u><\/strong>(2016) Effects of natural compound-loaded nanoparticles on metabolism of carbohydrates and lipids. 15th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), Taipei, Taiwan.<\/p>\n\n\n\n

27. Zhao, W.Z., Wang, H.T., Huang, H.J., Lo, Y.L.<\/u><\/strong>*<\/strong>, Lin, A.M.Y.*(2016) Neuroprotective effects of baicalein on acrolein-induced neurotoxicity in the nigrostriatal dopaminergic system of rat brain. 13th International Conference on Neuroprotective Agents (ICNA), Bilbao, Spain.<\/p>\n\n\n\n

28. Lo, Y.L.<\/u><\/strong>*, <\/strong>Tu, W.C., Lee, H.P. (2016) A nanoformulation of antimicrobial peptides and anticancer drugs in PEGylated liposomes inhibits multidrug resistance in different cancer cells. 2016 International Symposium on Theranostic Nanomedicine, Hsinchu, Taiwan.<\/p>\n\n\n\n

29. Lin K.H., Lin, M.Y., Yang, J.C.H., Lo, Y.L.<\/u>*<\/strong>(2016) Enhancing EGFR-TKIdeliveryacross the blood-brain barrier usingpharmaceutical excipients. The 31st<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09<\/strong>\u5341\u4e00\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

30. Lo, Y.L.<\/u><\/strong>*<\/strong>, Liu, Y.H., Ting, H.J. (2016) The use of zebrafish as a screening platform of anticancer agents. The 31st<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09<\/strong>\u5341\u4e00\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

31. Chen, L.Y.J., Ho, W.C., Lo, Y.L.,<\/u><\/strong> Yang, J.C.H., Lin, M.Y.*<\/strong>(2016) Role of EGFR in the astrocytes in response to hypoxia: potential neuroprotection of EGFR-TKIs. The 31st<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09<\/strong>\u5341\u4e00\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

32. Juang V.,Lee, H.P., Lo, Y.L.<\/u>*<\/strong>(2016) Anticancer mechanisms of liposomal epirubicin and antimicrobial peptide TH2-3 on cervical cancer cells. The 31st<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09<\/strong>\u5341\u4e00\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

33. Lo, Y.L.<\/u><\/strong>*<\/strong>, Liu, Y.H., Ting, H.J.,Tseng, D.Y. (2015) Development of a novel screening platform of anticancer agents using zebrafish as a model. 2015 Taiwan Zebrafish Symposium, Taipei, Taiwan.<\/p>\n\n\n\n

34. Lo, Y.L.<\/u><\/strong>*, <\/strong>Tu, W.C., Lee, H.P.(2015) The development of antimicrobial peptides as adjuvants to the current chemotherapy. The 7th<\/sup>Asian Association of Schools of Pharmacy (AASP) Conference (2015\u4e9e\u6d32\u85e5\u5b78\u9662\u6821\u806f\u5408\u6703\u5927\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

35. Lo, Y.L.<\/u><\/strong>*<\/strong>,Liu, Y.H., Ting, H.J. (2015) The use of an antimicrobial peptide from Red Sea sole as a multidrug resistance modulator in human cervical cancer cells. 14th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), London ON, Canada.<\/p>\n\n\n\n

36. Lo, Y.L.<\/u><\/strong>*<\/strong>,Tu, W.C. (2015) Development of CHY-1, an antimicrobial peptide and epirubicin in liposomes as an effective nanomedicine. The 30th<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09<\/strong>\u5341\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

37. Lin, G.L., Ting, H.J.,Lo, Y.L.<\/u>*<\/strong> (2015) The role of HuR in mediating the effect of epinecidin-1 and\/or epirubicin in colon adenocarcinoma SW620 cells.The 30th<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09\u5341\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u751f\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

38. Wang*, Y.T., Wang,H.T.Huang, H.J., Lo, Y.L<\/u><\/strong>.<\/strong>, Lin, M.Y. (2015) Oral acrolein induces neurotoxicity in rat brain: the involvement of apoptosis and neuroinflammation.The 30th<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e09<\/strong>\u5341\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

39. Liu, Y.H., Ting, H.J.,Lo, Y.L.<\/u>*<\/strong> (2015) Development of Antimicrobial Peptides as Adjuvants of Epirubicin, Conference of Bioresources and Technology, Tainan, Taiwan.<\/p>\n\n\n\n

40. Lin, G.L., Ting, H.J.,Lo, Y.L.<\/u>*<\/strong> (2015) The role of HuR in mediating the effect of antimicrobial peptide and\/or anticancer drug in colon adenocarcinoma cells. Conference of Bioresources and Technology, Tainan, Taiwan (\u69ae\u7372\u58c1\u5831\u6bd4\u8cfd\u7b2c\u4e00\u540d).<\/p>\n\n\n\n

41. Lo, Y.L.<\/u><\/strong>*<\/strong>, Lee, H.P. (2014) Hepcidin incorporated in liposomes as a new adjuvant to epirubicin. 7th<\/sup> World Congress on Preventive and Regenerative Medicine (\u7b2c\u4e03\u5c46\u9810\u9632\u8207\u518d\u751f\u91ab\u5b78\u4e16\u754c\u5e74\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

42. Lo, Y.L.<\/u><\/strong>*<\/strong>,Tu, W.C.(2014)The anticancer mechanisms of an antimicrobial peptide and epirubicin on human cervical cancer cells. The 7th Asian Pacific Organization forCell Biology Congress, Biopolis, Singapore.<\/p>\n\n\n\n

43. Lo, Y.L.<\/u><\/strong>*<\/strong>, Lee, H.P. (2014)Development of an antimicrobial peptide from tilapia as a new adjuvant to the current antineoplastic agent. The 29th<\/sup> Joint Annual Conference of Biomedical Science (\u7b2c\u4e8c\u5341\u4e5d\u5c46\u751f\u7269\u91ab\u5b78\u806f\u5408\u5b78\u8853\u5e74\u6703; \u6295\u7a3f\u5b78\u6703\uff1a\u53f0\u7063\u85e5\u7406\u5b78\u6703), Taipei, Taiwan.<\/p>\n\n\n\n

44. Lo, Y.L.<\/u>*<\/strong>,Lin, Y.J.,Lin, H.R.(2013)Colonic delivery of an antineoplastic agent in thermogelling and bioadhesive suppository formulations.The 13th Pacific Polymer Conference, Kaohsiung, Taiwan.<\/p>\n\n\n\n

45. Lo, Y.L.<\/u><\/strong>*<\/strong>, Wang, W.J. (2012)The study of anticancer mechanisms of daidzein in combination with epirubicin on human cervical cancer HeLa cells. The 39th Annual Meeting of the Controlled Release Society, Qu\u00e9bec City, Canada.<\/p>\n\n\n\n

46. Lo, Y.L.<\/u><\/strong>*<\/strong>, Hsu,C.Y.,Lin, H.R.(2011)\u6297\u764c\u85e5\u7269\u4e4b\u539f\u4f4d\u6210\u81a0\u8f38\u9001\u7cfb\u7d71, 100\u5e74\u5ea6\u300c\u751f\u5316\u53ca\u85e5\u7406\u91ab\u5b78\u5b78\u9580\u300d\u65b0\u77e5\u66a8\u5b78\u8853\u4ea4\u6d41\u7814\u8a0e\u6703, Taichung, Taiwan.<\/p>\n\n\n\n

47. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ho, C.T., Liu, Y.(2010)The cytotoxic effect and mechanisms of antisense oligonucleotides and epirubicin in liposomes on cancer cells. Conference of the Pharmaceutical Society of Taiwan, Taipei, Taiwan.<\/p>\n\n\n\n

48. C. Y., Hsu, Lo, Y.L.*<\/strong> (2010)\u53e3\u670d\u539f\u4f4d\u6210\u81a0\u6297\u764c\u85e5\u7269\u8f38\u9001\u7cfb\u7d71, 2010\u5357\u53f0\u7063\u7da0\u8272\u80fd\u6e90\u3001\u751f\u6280\u91ab\u7642\u7522\u696d\u6280\u8853\u767c\u8868\u6703, Kaohsiung, Taiwan.<\/p>\n\n\n\n

49. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ho, C.T., Liu, Y.(2010)A novel delivery system of antisense oligonucleotides and epirubicin for modulation of multidrug resistance. The 37th<\/sup>Annual Meeting of the Controlled Release Society, Portland, Oregon, USA.<\/p>\n\n\n\n

50. Lo, Y.L.<\/u><\/strong>*<\/strong>, Lin M.F., Ho, C.T. (2009)Useof anethole and epirubicin to inhibit pump and non-pump multidrug resistance. The 36th<\/sup>Annual Meeting of the Controlled Release Society, Copenhagen, Denmark.<\/p>\n\n\n\n

51. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ho, C.C., Ho, C.T. (2008)The effects and mechanisms of hesperidin and hesperetin on inhibiting pump and non-pump multidrug resistance. The IXth<\/sup> World Congress on Clinical Pharmacology and Therapeutics, Quebec, Canada.<\/p>\n\n\n\n

52. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ran, R.L., Ho, C.T. (2008)Effects and mechanisms of luteolin on modulation of multidrug resistance and induction of apoptosis in Caco-2 cells.The 35th<\/sup>Annual Meeting of the Controlled Release Society, New York, NY, USA.<\/p>\n\n\n\n

53. Tsai, C.S. and Lo, Y.L.<\/u><\/strong>* (2007)Effect of natural antioxidant on induction of apoptosis.2007 Annual Meeting of the Pharmaceutical Society of Taiwan, Tainan, Taiwan.<\/p>\n\n\n\n

54. Ho, C.C. and Lo, Y.L.<\/u>*<\/strong> (2007) Effect of Hesperitin on apoptosis induction in Caco-2 cells.The 1st <\/sup>International Cancer Symposium in CMU&H, Taichung, Taiwan.<\/p>\n\n\n\n

55. Lin, M.F. and Lo, Y.L.<\/u>* <\/strong>(2007) Effect of Emodin on apoptosis induction in Caco-2 cells.The 1st <\/sup>International Cancer Symposium in CMU&H, Taichung, Taiwan.<\/p>\n\n\n\n

56. Ran, R.L. and Lo, Y.L.<\/u>*<\/strong> (2007) Effect of Combination of Apigenin with Epirubicin on the Induction of Apoptosis in Caco-2 Cells. The 1st <\/sup>International Cancer Symposium in CMU&H, Taichung, Taiwan.<\/p>\n\n\n\n

57. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ho, C.T., Tsai, F.L. (2007)Effects and mechanisms of glycocholic acid on modulation of multidrug resistance and induction of apoptosis in Caco-2 cells. The 34th<\/sup>Annual Meeting of theControlled Release Society, Long Beach, CA, USA.<\/p>\n\n\n\n

58. Ho, C.C. and Lo, Y.L.<\/u>*<\/strong> (2007) Effect of Naringenin on apoptosis induction in Caco-2 cells. 22nd Symposium on Natural Products, Kaohsiung, Taiwan.<\/p>\n\n\n\n

59. Ran, R.L. and Lo, Y.L.<\/u>*<\/strong> (2007) Effect of Combination of Luteolin with Epirubicin on the Induction of Apoptosis in Caco-2 Cells. 22nd Symposium on Natural Products, Kaohsiung, Taiwan.<\/p>\n\n\n\n

60. Lin, M.F. and Lo, Y.L.<\/u>*<\/strong> (2007) Effect of silymarin on apoptosis induction in Caco-2 cells. The 22th Joint Annual Conference of Biomedical Sciences, Taipei, Taiwan.<\/p>\n\n\n\n

61. Ho, C.H. and Lo, Y.L.<\/u>*<\/strong> (2006)Effect and mechanisms of biochanin A on apoptosis induction in Caco-2 cells. Conference of the Pharmaceutical Society of Taiwan, Taichung, Taiwan.<\/p>\n\n\n\n

62. Ziu, R.L. and Lo, Y.L.<\/u>*<\/strong> (2006)Enhancement in apoptosis induction by the combination of estrogen and epirubicinin Caco-2 cells. Conference of the Pharmaceutical Society of Taiwan, Taichung, Taiwan.<\/p>\n\n\n\n

63. Lo, Y.L.<\/u><\/strong>*<\/strong>, Ho, C.T., Wu, Y.C. (2006)Effects and mechanisms of multiple modulators of p-glycoprotein and multidrug resistance-associated proteins on intestinal transport of epirubicin. The 33rd<\/sup>Annual Meeting of the Controlled Release Society, Vienna, Austria.<\/p>\n\n\n\n

64. Lin, H.R., Kao, H.J., Lo, Y.L.<\/u>*<\/strong>, andVong, W.J. (2006) In-situ<\/em> polyelectrolyte gelling systems for treating allergic conjunctivitis.The 33th<\/sup>Annual Meeting of the Controlled Release Society, Vienna, Austria.<\/p>\n\n\n\n

65. Lo, Y.L.<\/u><\/strong>*<\/strong>, Tsai, F.L., and Chen, C.R. (2005)Effect of glycocholic acid as a multidrug resistance modulator on the induction of apoptosis in Caco-2 cells. Conference of the Pharmaceutical Society of Republic of China, Tainan, Taiwan.<\/p>\n\n\n\n

66. Kao, H.J., Lo, Y.L.<\/u>*<\/strong>, Vong, W.J., and Lin H.R. (2005)In situ gelling polymers as ophthalmic delivery systems of cromolyn. Conference of the Pharmaceutical Society of Republic of China, Tainan, Taiwan.<\/p>\n\n\n\n

67. Lin, H. R., Yu, S.Y., Kuo, C. J., Kao, H. J., and Lo, Y.L.<\/u><\/strong> (2005) Chitosan-PAA nanoparticles for ophthalmic delivery of pilocarpine, 32nd <\/sup>Annual Meeting of the Controlled Release Society, Miami Beach, Florida.<\/p>\n\n\n\n

68. Lo, Y.L<\/u><\/strong>.*<\/strong> andTsai, J.C. (2005)Stabilization of spray-dried superoxide dismutase by liposomes and disaccharides: thermodynamic, conformational, and activity studies. Conference of the Chinese Society of Cell and Molecular Biology, Kenting, Taiwan.<\/p>\n\n\n\n

69. Yu, S.Y., Lin, H. R., Kuo, C. J., Kao, H. J., and Lo, Y.L.<\/u><\/strong> (2005) Chitosan-PAA nanoparticles for ophthalmic drug delivery, Taiwan Chitin-Chitosan Symposium, Tainan, Taiwan.<\/p>\n\n\n\n

70. Tsai, F.L. andLo, Y.L.<\/u><\/strong>*<\/strong>(2005)Effects of ursodeoxycholic acid and deoxycholic acid on the modulation of multidrug resistance-relatedproteins, P-glycoprotein, MRP1, MRP2, MRP3, and MRP4. Conference of the Chinese Society of Cell and Molecular Biology, Kenting, Taiwan.<\/p>\n\n\n\n

71. Kao, H.J., Lo, Y.L.<\/u><\/strong>, Lin H.R., and S. P. Yu (2004) In vitro\/ in vivo study of pilocarpine-loaded chitosan\/carbopol nanoparticles. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan.<\/p>\n\n\n\n

72. Tsai, F.L. andLo, Y.L.<\/u><\/strong>*<\/strong>(2004)Effects of glycocholic acid as a multidrug resistance modulator on the intestinal uptake of epirubicin. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan.<\/p>\n\n\n\n

73. Yu, S.Y., Lin, H. R., Kuo, C. J., Kao, H. J., and Lo, Y.L.<\/u><\/strong> (2004) Chitosan-PAA nanoparticles for ophthalmic drug delivery of pilocarpine, 2004 International Symposium on Nano Science and Technology, Tainan, Taiwan.<\/p>\n\n\n\n

74. Lo, Y.L.<\/u><\/strong>*<\/strong>and Wu, Y.J. (2004) Modulation of multidrug resistance by natural compounds in Caco-2 cells. 8th<\/sup> World Congress on Clinical Pharmacology and Therapeutics, Brisbane, Australia.<\/p>\n\n\n\n

75. Yu, S.Y., Lin, H. R., Kuo, C. J., Kao, H. J., and Lo, Y.L.<\/u><\/strong> (2004) Chitosan-PAA nanoparticles for ophthalmic delivery of pilocarpine, Taiwan-Japan Advanced Biomaterials Symposium, Taipei, Taiwan.<\/p>\n\n\n\n

76. Lo, Y.L.<\/u><\/strong>*<\/strong> (2004) Stabilization of spray-dried superoxide dismutase by liposomes and chitosan: surface characterization and relationship between activity and formulations. ROC-Japan Joint Symposium onParticle Design, Nanotechnology, and Drug Delivery, Hsinchu, Taiwan, R.O.C.<\/p>\n\n\n\n

77. Lo, Y.L.<\/u><\/strong>*, <\/strong>Dong, R.N., and Guo, H.C. (2004) Thermodynamic, conformation, and activity studies of protein-loaded liposomes with surfactants.ThePharmaceutical Symposium, Pingtung, Taiwan, R.O.C.<\/p>\n\n\n\n

78. Gao, H.J. and Lo, Y.L.<\/u><\/strong>*<\/strong>(2003) Study of pilocarpine-loaded chitosan\/poly (acrylic acid) nanoparticles.Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

79. Lo, Y.L.<\/u><\/strong>*<\/strong>(2003) Aerosol powder performance, interaction, and stability of spray-dried protein-loaded liposomes. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

80. Lo, Y.L.<\/u><\/strong>*<\/strong>and Gao, H.J. (2003) A Novel design of spray-dried protein-loaded liposomes. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

81. Wu, Y.J.and Lo, Y.L.<\/u><\/strong>*<\/strong> (2003) Effect of natural compounds as multidrug resistance modulators on the intestinal transport of epirubicin. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

82. Lo, Y.L.<\/u><\/strong>*, <\/strong>Kuo, J. H.(2002) Surface characterization of spray-dried superoxide dismutaseformulations.Conference of the Pharmaceutical Society of Republic of China, Pingtung, Taiwan, R.O.C.<\/p>\n\n\n\n

83. Kuo, J.H.,Lo, Y.L.<\/u>*<\/strong>,Cherng, J.Y., Shau, M.D.(2001) The stabilization study of biopolymers by spray-drying. The Joint Annual Conference of Polymer, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

84. Lo, Y.L.<\/u><\/strong>*<\/strong>,Kuo, J.H., Cherng, J.Y., Shau, M.D. (2001)Surface characterization and activity of lyophilized superoxide dismutase-loaded liposomes with different cryoprotectants. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

85. Tsai, J.C.*<\/strong>, Chen, I.H., Wong, T.K., and Lo, Y.L<\/u><\/strong>. (2001)In vitro\/in vivo correlation between transdermal delivery of 5-aminolevulinic acid and cutaneous PpIX accumulation and effect of formulation. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

86. Tsai, J.C.*<\/strong>, Lin, C.Y., Sheu, H.M., and Lo, Y.L.<\/u><\/strong>(2001)Rapid Infrared Spectrometric Quantitation of Stratum Corneum Lipid Content. Stratum Corneum III Conference, Basel, Switzerland<\/p>\n\n\n\n

87. Cherng, J.Y., Kuo, J.H.*<\/strong>, Lo, Y.L.<\/u><\/strong>, Shau, M.D. (2001) Pharmaceutical aspects of polymer-based gene delivery systems.The 28th<\/sup> International Symposium on Controlled Release of Bioactive Materials, San Diego, CA, USA.<\/p>\n\n\n\n

88. Lo, Y.L.<\/u><\/strong>*<\/strong>,Chen, L.T.,Lai, Y.W., and Chuang, Y.C. (2001)Effects of adjuvants on the stability of superoxide dismutase-loaded liposomes during freeze-drying, storage in the dried solid and incubation in the blood components. The 28th<\/sup> International Symposium on Controlled Release of Bioactive Materials, San Diego, CA, USA.<\/p>\n\n\n\n

89. Cherng, J.Y.*<\/strong>, Kuo, J.H., Lo, Y.L.<\/u><\/strong>, Shau, M.D. (2001) \u975e\u75c5\u6bd2\u6027\u8f09\u9ad4\uff08\u9ad8\u5206\u5b50\u805a\u5408\u7269\uff09\u61c9\u7528\u65bc\u57fa\u56e0\u50b3\u8f38\u7cfb\u7d71\u4e4b\u7814\u7a76. The 2001 Global Chinese Symposium on Biomaterials and Controlled Release, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

90. Tsai, J.C.*<\/strong>, Lin, C.Y., Sheu, H.M., and Lo, Y.L.<\/u><\/strong>(2000) Regional variation in stratum corneum permeability of 4-cyanophenol vs cimetidine by ATR-FTIR spectroscopy.2000 AAPS Annual Meeting, Indianapolis, IN, USA.<\/p>\n\n\n\n

91. Lo, Y.L.<\/u><\/strong>*<\/strong> and Chang, C.Y. (2000)Effect of cryoprotectants on the stability of superoxide dismutase liposomes. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

92. Lo, Y.L.<\/u><\/strong>*<\/strong> and Chen, C.R. (2000)Effect of superdisintegrants on the transport of epirubicin in Caco-2 cells and rat intestines. Conference of the Pharmaceutical Society of Republic of China, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

93. Lo, Y.L.<\/u><\/strong>*<\/strong>(2000) Effects of pharmaceutical excipients on the drug transport by P-glycoprotein. The Pharmaceutical symposium on Y2K, Pingtung, Taiwan, R.O.C.<\/p>\n\n\n\n

94. Tsai, J.C.*<\/strong>, Lin, C.Y., Sheu, H.M., and Lo, Y.L.<\/u><\/strong>(2000) Characterization of regional variation in human stratum corneum permeability by ATR-FTIR spectroscopy.The Pharmaceutical symposium on Y2K, Pingtung, Taiwan, R.O.C.<\/p>\n\n\n\n

95. Lo, Y.L.<\/u><\/strong>*<\/strong>,Chang, C.J., and Liu, F.I. (1999)Reversal of multidrug resistance of epirubicin by two different dosage forms of cyclosporines. Conference of the Pharmaceutical Society of Republic of China, Kaohsiung, Taiwan, R.O.C.<\/p>\n\n\n\n

96. Lo, Y.L.<\/u><\/strong>*<\/strong> (1999) Liposomal encapsulation on the efflux of epirubicin by P-glycoprotein. The 1999 Global Chinese Symposium on Biomaterials and Controlled Release, Taipei, Taiwan, R.O.C.<\/p>\n\n\n\n

97. Hsu, C.Y., Lo, Y.L.<\/u><\/strong>, and Huang, J.D.*<\/strong> (1998) The effects of bovine serum albumin (BSA) on the epirubicin transport by P-glycoprotein. The Thirteen Joint Annual Conference of Biomedical Sciences, Taipei, Taiwan, R.O.C. <\/p>\n\n\n\n

98. Lo, Y.L.<\/u><\/strong>*<\/strong> and Rahman, Y.E. (1995) Effects of membrane binding on the thermal stability of proteins using differential scanning calorimetry (DSC). AAPS Midwest Regional Meeting, Chicago, IL, USA.<\/p>\n\n\n\n

99. Lo, Y.L.<\/u><\/strong> and Rahman, Y.E.*<\/strong> (1995) Effects of Membrane binding on the conformational changes of proteins using Fourier transform infrared (FT-IR) spectroscopy. American Chemical Society 210th National Meeting, Chicago, IL, USA (SCI).<\/p>\n\n\n\n

100. Lo, Y.L.<\/u><\/strong>*<\/strong> and Rahman, Y.E. (1995) Effects of Membrane binding on the thermal stability and conformational changes of proteins using differential scanning calorimetry (DSC) and Fourier transform infrared (FT-IR) spectroscopy. AAPS Tenth Annual Meeting, Miami Beach, FL, USA. Pharm. Res.<\/strong> 12(9): S-209 (SCI).<\/p>\n\n\n\n

101. Lo, Y.L.<\/u><\/strong> and Rahman, Y.E.*<\/strong> (1995) Conformational changes of superoxide dismutase in DPPG liposomes using Fourier transform infrared (FT-IR) spectroscopy. AAPS Tenth Annual Meeting, Miami Beach, FL, USA. Pharm. Res.<\/strong> 12(9): S-209 (SCI).<\/p>\n\n\n\n

102. Lo, Y.L.<\/u><\/strong> and Rahman, Y.E.*<\/strong> (1994) Prediction of protein drug location in liposomes by differential scanning calorimetry (DSC). AAPS Ninth Annual Meeting, San Diego, CA, USA. Pharm. Res.<\/strong> 11(10): S-324 (SCI).<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

\u25cf \u8fa6 \u516c \u5ba4\uff1a\u5b88\u4ec1\u6a135\u6a13516\u5ba4 \u25cf \u806f\u7d61\u96fb\u8a71\uff1a(02) 2826-7000 … Continue reading →<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-330","page","type-page","status-publish","hentry"],"yoast_head":"\n\u99f1\u96e8\u5229 \u6559\u6388 - \u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mph.nycu.edu.tw\/en\/\u99f1\u96e8\u5229-\u6559\u6388\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u99f1\u96e8\u5229 \u6559\u6388 - \u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b\" \/>\n<meta property=\"og:description\" content=\"\u25cf \u8fa6 \u516c \u5ba4\uff1a\u5b88\u4ec1\u6a135\u6a13516\u5ba4 \u25cf \u806f\u7d61\u96fb\u8a71\uff1a(02) 2826-7000 … Continue reading →\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mph.nycu.edu.tw\/en\/\u99f1\u96e8\u5229-\u6559\u6388\/\" \/>\n<meta property=\"og:site_name\" content=\"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NYCUMPH\/\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-11T05:40:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"28 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/\",\"url\":\"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/\",\"name\":\"\u99f1\u96e8\u5229 \u6559\u6388 - \u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b\",\"isPartOf\":{\"@id\":\"https:\/\/mph.nycu.edu.tw\/#website\"},\"datePublished\":\"2021-01-21T07:40:35+00:00\",\"dateModified\":\"2022-05-11T05:40:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\/\/mph.nycu.edu.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u99f1\u96e8\u5229 \u6559\u6388\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mph.nycu.edu.tw\/#website\",\"url\":\"https:\/\/mph.nycu.edu.tw\/\",\"name\":\"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b\",\"description\":\"Master of Public Health Program, National Yang Ming Chiao Tung University\",\"publisher\":{\"@id\":\"https:\/\/mph.nycu.edu.tw\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mph.nycu.edu.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mph.nycu.edu.tw\/#organization\",\"name\":\"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b\",\"url\":\"https:\/\/mph.nycu.edu.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mph.nycu.edu.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mph.nycu.edu.tw\/wp-content\/uploads\/2024\/03\/cropped-NYCU_logo.svg_.png\",\"contentUrl\":\"https:\/\/mph.nycu.edu.tw\/wp-content\/uploads\/2024\/03\/cropped-NYCU_logo.svg_.png\",\"width\":512,\"height\":512,\"caption\":\"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b\"},\"image\":{\"@id\":\"https:\/\/mph.nycu.edu.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/NYCUMPH\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u99f1\u96e8\u5229 \u6559\u6388 - \u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mph.nycu.edu.tw\/en\/\u99f1\u96e8\u5229-\u6559\u6388\/","og_locale":"en_US","og_type":"article","og_title":"\u99f1\u96e8\u5229 \u6559\u6388 - \u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b","og_description":"\u25cf \u8fa6 \u516c \u5ba4\uff1a\u5b88\u4ec1\u6a135\u6a13516\u5ba4 \u25cf \u806f\u7d61\u96fb\u8a71\uff1a(02) 2826-7000 … Continue reading →","og_url":"https:\/\/mph.nycu.edu.tw\/en\/\u99f1\u96e8\u5229-\u6559\u6388\/","og_site_name":"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b","article_publisher":"https:\/\/www.facebook.com\/NYCUMPH\/","article_modified_time":"2022-05-11T05:40:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"28 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/","url":"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/","name":"\u99f1\u96e8\u5229 \u6559\u6388 - \u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b","isPartOf":{"@id":"https:\/\/mph.nycu.edu.tw\/#website"},"datePublished":"2021-01-21T07:40:35+00:00","dateModified":"2022-05-11T05:40:00+00:00","breadcrumb":{"@id":"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mph.nycu.edu.tw\/%e9%a7%b1%e9%9b%a8%e5%88%a9-%e6%95%99%e6%8e%88\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/mph.nycu.edu.tw\/"},{"@type":"ListItem","position":2,"name":"\u99f1\u96e8\u5229 \u6559\u6388"}]},{"@type":"WebSite","@id":"https:\/\/mph.nycu.edu.tw\/#website","url":"https:\/\/mph.nycu.edu.tw\/","name":"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b","description":"Master of Public Health Program, National Yang Ming Chiao Tung University","publisher":{"@id":"https:\/\/mph.nycu.edu.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mph.nycu.edu.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mph.nycu.edu.tw\/#organization","name":"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b","url":"https:\/\/mph.nycu.edu.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mph.nycu.edu.tw\/#\/schema\/logo\/image\/","url":"https:\/\/mph.nycu.edu.tw\/wp-content\/uploads\/2024\/03\/cropped-NYCU_logo.svg_.png","contentUrl":"https:\/\/mph.nycu.edu.tw\/wp-content\/uploads\/2024\/03\/cropped-NYCU_logo.svg_.png","width":512,"height":512,"caption":"\u570b\u7acb\u967d\u660e\u4ea4\u901a\u5927\u5b78 \u516c\u5171\u885b\u751f\u78a9\u58eb\u5b78\u4f4d\u5b78\u7a0b"},"image":{"@id":"https:\/\/mph.nycu.edu.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NYCUMPH\/"]}]}},"_links":{"self":[{"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/pages\/330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/comments?post=330"}],"version-history":[{"count":27,"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/pages\/330\/revisions"}],"predecessor-version":[{"id":2497,"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/pages\/330\/revisions\/2497"}],"wp:attachment":[{"href":"https:\/\/mph.nycu.edu.tw\/en\/wp-json\/wp\/v2\/media?parent=330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}